These receptors can reprogram inflammatory transcription, upregulate immune-regulatory mediators, and promote protumor cell–cell interactions beyond tumor epithelial cells, highlighting the existence of a genuine AR–myeloid axis to add to that of tumor epithelial cells (7). This evidence concerns the gene AR and neoplasm.